Roivant Sciences Stock Net Asset
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Roivant |
Roivant Sciences Company Net Asset Analysis
Roivant Sciences' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Roivant Sciences Net Asset | 2.39 B |
Most of Roivant Sciences' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Roivant Sciences has a Net Asset of 2.39 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Roivant Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in net asset category among its peers.
Roivant Fundamentals
| Operating Margin | (37.08) % | |||
| Number Of Shares Shorted | 215.84 K | |||
| Revenue | 61.28 M | |||
| EBITDA | (1.11 B) | |||
| Net Income | (1.12 B) | |||
| Cash And Equivalents | 2 B | |||
| Cash Per Share | 8.97 X | |||
| Total Debt | 481.4 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 9.84 X | |||
| Book Value Per Share | 7.74 X | |||
| Cash Flow From Operations | (843.39 M) | |||
| Earnings Per Share | (4.09) X | |||
| Number Of Employees | 620 | |||
| Total Asset | 2.39 B | |||
| Retained Earnings | (3.77 B) | |||
| Working Capital | 1.53 B | |||
| Z Score | -2.95 | |||
| Net Asset | 2.39 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Roivant Stock
If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |